Search Results - José Baselga

Refine Results
  1. 1
    Clinical trials of Herceptin® (trastuzumab)

    Clinical trials of Herceptin® (trastuzumab) by José Baselga

    Published 2001
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Treatment of HER2-overexpressing breast cancer

    Treatment of HER2-overexpressing breast cancer by José Baselga

    Published 2010
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Phase I and II clinical trials of trastuzumab

    Phase I and II clinical trials of trastuzumab by José Baselga

    Published 2001
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Targeting the Phosphoinositide-3 (PI3) Kinase Pathway in Breast Cancer

    Targeting the Phosphoinositide-3 (PI3) Kinase Pathway in Breast Cancer by José Baselga

    Published 2011
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Why the Epidermal Growth Factor Receptor? The Rationale for Cancer Therapy

    Why the Epidermal Growth Factor Receptor? The Rationale for Cancer Therapy by José Baselga

    Published 2002
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Focus on breast cancer

    Focus on breast cancer by José Baselga, Larry Norton

    Published 2002
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Unraveling Resistance to Trastuzumab (Herceptin): Insulin-Like Growth Factor-I Receptor, a New Suspect

    Unraveling Resistance to Trastuzumab (Herceptin): Insulin-Like Growth Factor-I Receptor, a New Suspect by J. Albanell, José Baselga

    Published 2001
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  8. 8
    Determinants of <i>RAS</i>istance to Anti–Epidermal Growth Factor Receptor Agents

    Determinants of <i>RAS</i>istance to Anti–Epidermal Growth Factor Receptor Agents by José Baselga, Neal Rosen

    Published 2008
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Mechanism of action of anti-HER2 monoclonal antibodies

    Mechanism of action of anti-HER2 monoclonal antibodies by José Baselga, Joan Albanell

    Published 2001
    Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Targeting the Microtubules in Breast Cancer Beyond Taxanes: The Epothilones

    Targeting the Microtubules in Breast Cancer Beyond Taxanes: The Epothilones by Javier Cortés, José Baselga

    Published 2007
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Targeted therapies for breast cancer

    Targeted therapies for breast cancer by Michaela J. Higgins, José Baselga

    Published 2011
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Tyrosine kinase inhibitors

    Tyrosine kinase inhibitors by Carlos L. Arteaga, José Baselga

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Impact of Genomics on Personalized Cancer Medicine

    Impact of Genomics on Personalized Cancer Medicine by Carlos L. Arteaga, José Baselga

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Trastuzumab-DM1: Building a Chemotherapy-Free Road in the Treatment of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

    Trastuzumab-DM1: Building a Chemotherapy-Free Road in the Treatment of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer by Steven J. Isakoff, José Baselga

    Published 2010
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  15. 15
    Critical Update and Emerging Trends in Epidermal Growth Factor Receptor Targeting in Cancer

    Critical Update and Emerging Trends in Epidermal Growth Factor Receptor Targeting in Cancer by José Baselga, Carlos L. Arteaga

    Published 2005
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Molecular Pathways: AXL, a Membrane Receptor Mediator of Resistance to Therapy

    Molecular Pathways: AXL, a Membrane Receptor Mediator of Resistance to Therapy by Maurizio Scaltriti, Moshe Elkabets, José Baselga

    Published 2016
    Get full text
    Revisão
    Save to List
    Saved in:
  17. 17
    The Evolving War on Cancer

    The Evolving War on Cancer by Daniel A. Haber, Nathanael S. Gray, José Baselga

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Deconstructing feedback-signaling networks to improve anticancer therapy with mTORC1 inhibitors

    Deconstructing feedback-signaling networks to improve anticancer therapy with mTORC1 inhibitors by Arkaitz Carracedo, José Baselga, Pier Paolo Pandolfi

    Published 2008
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    Implementing Genome-Driven Oncology

    Implementing Genome-Driven Oncology by David M. Hyman, Barry S. Taylor, José Baselga

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  20. 20
    A view on drug resistance in cancer

    A view on drug resistance in cancer by Neil Vasan, José Baselga, David M. Hyman

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:

Search Tools: